An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 27, 2009, Pages 11154-11159

  Kim, Marianne K H ^a   McGarry, Thomas J ^a   Broin, Pilib Ó ^b   Flatow, Jared M ^a   Golden, Aaron A J ^b   Licht, Jonathan D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

ChIP ChIP; Microarray; Tumor suppressor

Indexed keywords

BETA CATENIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MAZ; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR ZNF219; UNCLASSIFIED DRUG; WNT PROTEIN; WT1 PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENETIC IDENTIFICATION; GENETIC SCREENING; GENOME; HUMAN; HUMAN CELL; MUTANT; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; WILD TYPE; XENOPUS;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CREB-BINDING PROTEIN; DNA; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC SCREENING; GENOME; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WNT PROTEINS; WT1 PROTEINS; XENOPUS;

EID: 67650495106     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0901591106     Document Type: Article

References (50)

1. Ogawa O, et al. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362:749-751.
2. Lee SB, Haber DA (2001) Wilms tumor and the WT1 gene. Exp Cell Res 264:74-99.
3. Rivera MN, et al. (2007) An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315:642-645.
4. Maiti S, Alam R, Amos CI, Huff V (2000) Frequent association of beta-catenin and WT1 mutations in Wilms tumors. Cancer Res 60:6288-6292.
5. Koesters R, et al. (1999) Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 59:3880-3882.
6. Uschkereit C, et al. (2007) Different CTNNB1 mutations as molecular genetic proof for the independent origin of four Wilms tumours in a patient with a novel germ line WT1 mutation. J Med Genet 44:393-396.
7. Li CM, et al. (2004) CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors. Am J Pathol 165:1943-1953.
8. Scharnhorst V,DekkerP,vanderEbAJ,JochemsenAG(1999) Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties. J Biol Chem 274:23456-23462.
9. Bickmore WA, et al. (1992) Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science 257:235-237.
10. Herzer U, Crocoll A, Barton D, Howells N, Englert C (1999) The Wilms tumor suppressor gene wt1 is required for development of the spleen. Curr Biol 9:837-840.
11. Wagner N, Wagner KD, Scholz H, Kirschner KM, Schedl A (2006) Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1. Am J Physiol Regul Integr Comp Physiol 291:R779-R787.
12. Ijpenberg A, et al. (2007) Wt1 and retinoic acid signaling are essential for stellate cell development and liver morphogenesis. Dev Biol 312:157-170.
13. Morrison DJ, Kim MK, Berkofsky-Fessler W, Licht JD (2008) WT1 induction of mitogenactivated protein kinase phosphatase 3 represents a novel mechanism of growth suppression. Mol Cancer Res 6:1225-1231.
14. Fraizer G, et al. (2004) Suppression of prostatetumorcellgrowthin vivobyWT1,the Wilms' tumor suppressor gene. Int J Oncol 24:461-471.
15. Zhang TF, Yu SQ, Guan LS, Wang ZY (2003) Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin. Anticancer Res 23(5A):3575-3584.
16. Englert C, et al. (1995) WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14:4662-4675.
17. HaberDA,et al. (1993)WT1-mediatedgrowthsuppression ofWilmstumorcells expressing a WT1 splicing variant. Science 262:2057-2059.
18. Luo XN, et al. (1995) The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene 11:743-750.
19. Oji Y, et al. (2003) Overexpression of the Wilms'tumorgeneWT1in primary thyroid cancer. Cancer Sci 94:606-611.
20. Oji Y, et al. (2003) Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma. Cancer Sci 94:712-717.
21. Kim MK, et al. (2008) A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16. Neoplasia 10:69-78.
22. Englert C, Maheswaran S, Garvin AJ, Kreidberg J, HaberDA(1997) Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res 57:1429-1434.
23. Lee SB, et al. (1999) The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell 98:663-673.
24. Sim EU, et al. (2002) Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1. Oncogene 21:2948-2960.
25. Gross I, et al. (2003)Thereceptor tyrosine kinase regulator Sprouty1 isatarget of thetumor suppressor WT1 and important for kidney development. J Biol Chem 278:41420-41430.
26. Bridgewater D, et al. (2008) Canonical WNT/beta-catenin signaling is required for ureteric branching. Dev Biol 317:83-94.
27. Morrison DJ, English MA, Licht JD (2005) WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. Cancer Res 65:8174-8182.
28. Roth FP, Hughes JD, Estep PW, Church GM (1998) Finding DNA regulatory motifs within unaligned noncoding sequences clustered by whole-genome mRNA quantitation. Nat Biotechnol 16:939-945.
29. Bailey TL, Elkan C (1994) Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 2:28-36.
30. Mahony S, Hendrix D, Golden A, Smith TJ, Rokhsar DS (2005) Transcription factor binding site identification using the self-organizing map. Bioinformatics 21:1807-1814.
31. Wingender E, et al. (2000) TRANSFAC: An integrated system for gene expression regulation. Nucleic Acids Res 28:316-319.
32. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B (2004) JASPAR: An open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32:D91-D94.
33. Quandt K, Frech K, Karas H, Wingender E, Werner T (1995) MatInd and MatInspector:New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23:4878-4884.
34. Piper M, Georgas K,Yamada T, Little M(2000) Expression of the vertebrate Slit gene family and their putative receptors, the Robo genes, in the developing murine kidney. Mech Dev 94(1-2):213-217.
35. He TC, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
36. Udtha M, Lee SJ, Alam R, Coombes K, Huff V(2003) Up-regulation ofc-MYCinWT1-mutant tumors: Assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors. Oncogene 22:3821-3826.
37. Takemaru KI, Moon RT (2000) The transcriptional coactivator CBP interacts with betacatenin to activate gene expression. J Cell Biol 149:249-254.
38. Wang W, Lee SB, Palmer R, Ellisen LW, Haber DA (2001) A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1. J Biol Chem 276:16810-16816.
39. Hatzis P, et al. (2008) Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol 28:2732-2744.
40. Yochum GS, et al. (2007) Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells. Proc Natl Acad Sci USA 104:3324-3329.
41. Vainio SJ, Uusitalo MS (2000) A road to kidney tubules via the Wnt pathway. Pediatr Nephrol 15(1-2):151-156.
42. Schmidt-Ott KM, Lan D, Hirsh BJ, Barasch J (2006) Dissecting stages of mesenchymal-toepithelial conversion during kidney development. Nephron Physiol 104:56-60.
43. Nusse R (2007) Cancer. Converging on beta-catenin in Wilms tumor. Science 316:988-989.
44. Park JS, Valerius MT, McMahon AP (2007) Wnt/beta-catenin signaling regulates nephron induction during mouse kidney development. Development 134:2533-2539.
45. Fukuzawa R, et al. (2004) Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway. Pediatr Dev Pathol 7:125-137.
46. Chang H, et al. (2008) Wt1 negatively regulates beta-catenin signaling during testis development. Development 135:1875-1885.
47. Kamei Y, et al. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
48. Ghosh AK, Yuan W, Mori Y, Chen S, Varga J (2001) Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem 276:11041-11048.
49. Eisermann K, et al. (2008) Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer. BMC Genomics 9:337.
50. Mahony S, Benos PV (2007) STAMP: A web tool for exploring DNA-binding motif similarities. Nucleic Acids Res 35:W253-W258.